* Spin-off finalized within five months following board resolution * Proposal approved in shareh...
* Recorded Q3'25 consolidated revenue of KRW 1,660.2 billion * Recorded Q3'25 consolidated opera...
* ExellenS TM applies optimized facility designs, equipment, and processes across all sites to en...
* Recorded Q2'25 consolidated revenue of KRW 1,289.9 billion * Recorded Q2'25 consolidated opera...
* Samsung Organoids to provide data-driven analysis of candidate molecules * Samsung Biologics e...
* Recorded Q1'25 consolidated revenue of KRW 1.3 trillion * Recorded Q1'25 consolidated operatin...
- Company receives leadership status and A- rating for efficient water resources management -...
* Recorded Q4'24 consolidated revenue of KRW 1.26 trillion * Recorded FY'24 consolidated reven...
- The company to mark new phase of growth at Bio Campus II with the opening of Plant 5 in April - ...
* Samsung Biologics to offer ADC services at new dedicated facility * Extended collaboration ref...
* Samsung Biologics to offer ADC services at new dedicated facility * Extended collaboration ref...
- Samsung Life Science Fund invests in Generate:Biomedicines, a Flagship Pioneering company leading...
* Acknowledged for strong environmental, social, and governance (ESG) performance and continued c...
INCHEON, South Korea, Dec. 3, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global con...
* The company will provide manufacturing services through 2031 in deals worth overUSD 668 million...
* The company adds new ISO certification for compliance management and certified to updated stand...
* Recorded Q3'24 consolidated revenue of KRW 1.2 trillion * Recorded Q3'24 consolidated operatin...
* S-HiConTM is designed to maximize drug delivery and stability through high-concentration formul...
* Samsung Biologics showcases new innovative development platforms – S-AfuCHO TM and S-OptiChargeT...
* Samsung Biologics to embed PSCI principles into business practices for responsible value chain ...